RACHELLE SCHNEITER: Open Payments
NPI 1427481910 · ASHTABULA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 41 payments from 9 companies in 2025. Trend: 2023 $6,727 · 2024 $1,458 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $370 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $187 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
| Neurocrine BioSciences, Inc. | 5 | $94 |
| Sage Therapeutics, LLC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
Products named: REXULTI, CAPLYTA, COBENFY, INGREZZA, ABILIFY ASIMTUFII, ZURZUVAE, Qelbree, VRAYLAR.
Industry payments across OH — which companies pay providers there.
